Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study – a randomised, double-blind cross-over study using mixed microbiota from healthy donors
Introduction Several studies have demonstrated dysbiosis in irritable bowel syndrome (IBS). Therefore, faecal microbiota transplantation, whose effect and safety have been proven in Clostridioides difficile infections, may hold promise in other conditions, including IBS. Our study will examine the e...
Saved in:
Main Authors: | Lenka Kramna, Ondrej Cinek, Jakub Hurych, Jiri Vejmelka, Lucie Hlinakova, Vladyslav Larionov, Michal Kulich, Pavel Kohout |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e056594.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Validation methods for encapsulated faecal microbiota transplantation: a scoping review
by: Nina Rågård, et al.
Published: (2025-02-01) -
Irritable Bowel Syndrome in Terms of Changes in the Microbiota
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01) -
Structural characterization of oligosaccharide from Spirulina platensis and its effect on the faecal microbiota in vitro
by: Bingna Cai, et al.
Published: (2022-01-01) -
Pathogenetic Substantiation of the Therapeutic Impact on Microbiota in Irritable Bowel Syndrome
by: Yu. O. Shulpekova, et al.
Published: (2019-09-01) -
Irritable Bowel Syndrome: Gut Microbiota Dysbiosis and Psychological Co-morbidities
by: Bijita Bhowmick, et al.
Published: (2025-01-01)